Multimodality treatment of anaplastic thyroid cancer with nearly resolved effect

被引：2
|
作者：
Tseng, Yu-Ting
Chang, Tien-Chun [1 ,2 ]
机构：
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2015年 / 114卷 / 09期
关键词：
D O I：
10.1016/j.jfma.2014.03.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：897 / 898
页数：2
相关论文
共 50 条
  • [41] Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer
    Gentile, Daniela
    Orlandi, Paola
    Banchi, Marta
    Bocci, Guido
    MEDICAL ONCOLOGY, 2020, 37 (03)
  • [42] Recent advances in precision medicine for the treatment of anaplastic thyroid cancer
    Ferrari, Silvia Martina
    Fallahi, Poupak
    La Motta, Concettina
    Elia, Giusy
    Ragusa, Francesca
    Ruffilli, Ilaria
    Patrizio, Armando
    Baldini, Enke
    Ulisse, Salvatore
    Antonelli, Alessandro
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (01): : 37 - 49
  • [43] Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment
    Jonker, Pascal K. C.
    Turchini, John
    Kruijff, Schelto
    Lin, Jia Feng
    Gill, Anthony J.
    Eade, Thomas
    Ahniss, Ahmad
    Clifton-Bligh, Roderick
    Learoyd, Diana
    Robinson, Bruce
    Tsang, Venessa
    Glover, Anthony
    Sidhu, Stanley
    Sywak, Mark
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7520 - 7530
  • [44] Survival Benefit of Intervention Treatment in Advanced Anaplastic Thyroid Cancer
    Kasemsiri, Pornthep
    Chaisakgreenon, Pimpika
    Vatanasapt, Patravoot
    Laohasiriwong, Supawan
    Teeramatwanich, Watchareeporn
    Thongrong, Cattleya
    Ratanaanekchai, Teeraporn
    Suetrong, Surapol
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2021, 2021
  • [45] Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment
    Pascal K. C. Jonker
    John Turchini
    Schelto Kruijff
    Jia Feng Lin
    Anthony J. Gill
    Thomas Eade
    Ahmad Aniss
    Roderick Clifton-Bligh
    Diana Learoyd
    Bruce Robinson
    Venessa Tsang
    Anthony Glover
    Stanley Sidhu
    Mark Sywak
    Annals of Surgical Oncology, 2021, 28 : 7520 - 7530
  • [46] Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review
    Guerra, Anna
    Di Crescenzo, Vincenzo
    Garzi, Alfredo
    Cinelli, Mariapia
    Carlomagno, Chiara
    Tonacchera, Massimo
    Zeppa, Pio
    Vitale, Mario
    BMC SURGERY, 2013, 13
  • [47] Lenvatinib as a novel treatment for anaplastic thyroid cancer: A retrospective study
    Iwasaki, Hiroyuki
    Yamazaki, Haruhiko
    Takasaki, Hirotaka
    Suganuma, Nobuyasu
    Nakayama, Hirotaka
    Toda, Soji
    Masudo, Katsuhiko
    ONCOLOGY LETTERS, 2018, 16 (06) : 7271 - 7277
  • [48] Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer
    Sekihara, Kazumasa
    Himuro, Hidetomo
    Toda, Soji
    Saito, Nao
    Hirayama, Ryoichi
    Suganuma, Nobuyasu
    Sasada, Tetsuro
    Hoshino, Daisuke
    BIOMEDICINES, 2024, 12 (06)
  • [49] Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer
    De Andrade, James P.
    Lorenzen, Allison W.
    Wu, Vincent T.
    Bogachek, Maria V.
    Park, Jung M.
    Gu, Vivian W.
    Sevenich, Claire M.
    Cassady, Victoria C.
    Beck, Anna C.
    Kulak, Mikhail V.
    Robinson, Robert A.
    Lal, Geeta
    Weigel, Ronald J.
    ONCOTARGET, 2017, 8 (70) : 114801 - 114815
  • [50] Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer
    Daniela Gentile
    Paola Orlandi
    Marta Banchi
    Guido Bocci
    Medical Oncology, 2020, 37
12345